AUXL

Auxilium Pharmaceuticals, Inc. Press Releases

$19.24
*  
0.36
1.84%
Get AUXL Alerts
*Delayed - data as of Jul. 24, 2014  -  Find a broker to begin trading AUXL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Sale of Auxilium Pharmaceuticals Inc.: - AUXL
7/8/2014 5:04:00 PM - PR Newswire

AUXILIUM PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Auxilium Pharmaceuticals Inc. Board of Directors in Connection With the Proposed Sale of the Company to QLT Inc.
7/7/2014 6:15:00 PM - Business Wire

Lifshitz & Miller Law Firm Announces Investigation of Auxilium Pharmaceuticals Inc., First Citizens Bancorporation, Medical Action Industries Inc., Regado Biosciences, Inc., Sport Chalet Inc., and Vitacost.com, Inc.
7/4/2014 1:43:00 PM - PR Newswire

AUXILIUM PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
6/30/2014 11:00:00 AM - Business Wire

Newman Ferrara LLP Announces Investigation of Auxilium Pharmaceuticals, Inc.
6/30/2014 10:23:00 AM - Business Wire

AUXILIUM PHARMACEUTICALS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Auxilium Pharmaceuticals Inc. Over the Proposed Sale of the Company to QLT Inc.
6/27/2014 7:00:00 PM - PR Newswire

Auxilium Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate the Merger with QLT Inc.
6/27/2014 12:03:00 PM - Business Wire

The Wohl & Fruchter LLP Law Firm is Investigating the Acquisition of Auxilium Pharmaceuticals, Inc. by QLT, Inc.
6/26/2014 2:06:00 PM - Business Wire

AUXILIUM PHARMACEUTICALS INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Auxilium Pharmaceuticals Inc. Over the Proposed Sale of the Company to QLT Inc.
6/26/2014 11:59:00 AM - Business Wire

Auxilium Pharmaceuticals to Merge with Canadian Biotechnology Company QLT
6/26/2014 7:00:00 AM - PR Newswire

Sobi files for EU approval of Xiapex for Peyronies disease
6/25/2014 8:00:00 AM - GlobeNewswire

Auxilium Pharmaceuticals, Inc. Announces Launch Of Authorized Generic Version Of Testim (Testosterone Gel)
6/11/2014 7:00:00 AM - PR Newswire

Auxilium Pharmaceuticals, Inc. Announces Departure of Chief Financial Officer
6/2/2014 4:30:00 PM - PR Newswire

Auxilium Pharmaceuticals, Inc. To Present At The Jefferies Healthcare Conference
5/30/2014 9:00:00 AM - PR Newswire

Top Gainers under Review -- Research on Stratasys, Auxilium Pharma, Catalyst Pharma Partners, and Real Goods Solar
5/23/2014 8:40:00 AM - PR Newswire

Auxilium Pharmaceuticals, Inc. Presents New Analyses Of XIAFLEX Peyronie's Disease Data At Urology Meeting
5/19/2014 7:00:00 AM - PR Newswire

Auxilium Pharmaceuticals, Inc. To Present At The UBS Healthcare Conference
5/12/2014 6:00:00 AM - PR Newswire

Auxilium Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results
5/5/2014 6:00:00 AM - PR Newswire

Auxilium Pharmaceuticals, Inc. to Present at the Deutsche Bank Healthcare Conference
5/1/2014 6:00:00 AM - PR Newswire

Auxilium Pharmaceuticals, Inc. Lowers 2014 Financial Guidance
4/29/2014 7:05:00 PM - PR Newswire

Auxilium Pharmaceuticals, Inc. Announces Presentation Of Data For XIAFLEX At Urology Meeting
4/28/2014 7:00:00 AM - PR Newswire